Homepage — Immunology

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© © University of Oxford Images / John Cairns Photography

Oxford and GSK launch £50m programme to advance cancer research

Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.

Read more

Launch of 'To Immunity and Beyond' podcast series

Read more

Pancreatic cancer immune map provides clues for precision treatment targeting

Study shows why there are differences in prognosis between different pancreatic tumours and identifies potential avenues for improved treatment approaches.

Read more

Latest News

Scientists in the Department of Paediatrics discover antibody combinations that block over 90% of malaria parasite growth

12 June 2026

Interleukin 10 (IL-10) cytokine protein - looks like a red ribbon

Decades old puzzle solved as scientists uncover cause of inflammatory bowel disease

11 June 2026

A cancer cell is being targeted by immune T cells

Researchers uncover hidden mechanism behind a major cancer therapy target

9 June 2026

Workshop post-it stickers on what does immunology tolerance mean to you

Sounds of Tolerance

4 June 2026

Professor Teresa Lambe

Oxford Bundibugyo ebolavirus vaccine candidate receives CEPI backing

1 June 2026

Irina Udalova

Major MRC funding for Irina Udalova to unravel neutrophil behaviour across immune pathologies

28 May 2026

See all news

Upcoming Talks

From Naïve and CD4 T Cell Diversity to Therapeutic Design

Friday, 26 June 2026, 9.15am to 10.15am

Molecular recognition of the nucleosome by chromatin enzymes and factors

Friday, 26 June 2026, 11.15am to 12.15pm

Oxford Transcription and RNA Club seminar and networking: Imaging non-coding RNAs in the nucleus at single-molecule resolution

Friday, 26 June 2026, 3pm to 5pm

Constrained B-cell development promotes malignant transformation

Monday, 29 June 2026, 11am to 12pm

Oxford Palliative Care Academic Network Summer Research Symposium

Tuesday, 30 June 2026, 9am to 4pm

Lunchtime Lab Talks: Stephanie Dakin, NDORMS

Wednesday, 01 July 2026, 12.30pm to 1.30pm

Timing Matters: How Hormonal Rhythms Govern Mutation Spread, Cancer Initiation, and Treatment Response

Thursday, 02 July 2026, 11am to 12pm

Latest publications

The double-edged nature of antibody bivalency: mathematical and experimental analysis of cell surface antigen occupancy and opsonization.

Heirene L. et al, (2026), MAbs, 18

DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.

Morgado-Cáceres P. et al, (2026), Oncoimmunology, 15

Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.

van Niekerk L. et al, (2026), MAbs, 18

Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production.

Schulz A. et al, (2026), MAbs, 18